1. Home
  2. BNGO vs PFSA Comparison

BNGO vs PFSA Comparison

Compare BNGO & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNGO
  • PFSA
  • Stock Information
  • Founded
  • BNGO 2003
  • PFSA 2009
  • Country
  • BNGO United States
  • PFSA United States
  • Employees
  • BNGO N/A
  • PFSA N/A
  • Industry
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • PFSA Medical/Dental Instruments
  • Sector
  • BNGO Industrials
  • PFSA Health Care
  • Exchange
  • BNGO Nasdaq
  • PFSA Nasdaq
  • Market Cap
  • BNGO 24.3M
  • PFSA 25.1M
  • IPO Year
  • BNGO 2018
  • PFSA N/A
  • Fundamental
  • Price
  • BNGO $2.02
  • PFSA $0.34
  • Analyst Decision
  • BNGO Buy
  • PFSA
  • Analyst Count
  • BNGO 4
  • PFSA 0
  • Target Price
  • BNGO $7.67
  • PFSA N/A
  • AVG Volume (30 Days)
  • BNGO 1.6M
  • PFSA 15.6M
  • Earning Date
  • BNGO 11-12-2025
  • PFSA 11-20-2025
  • Dividend Yield
  • BNGO N/A
  • PFSA N/A
  • EPS Growth
  • BNGO N/A
  • PFSA N/A
  • EPS
  • BNGO N/A
  • PFSA N/A
  • Revenue
  • BNGO $27,426,000.00
  • PFSA $75,000.00
  • Revenue This Year
  • BNGO N/A
  • PFSA N/A
  • Revenue Next Year
  • BNGO $24.54
  • PFSA N/A
  • P/E Ratio
  • BNGO N/A
  • PFSA N/A
  • Revenue Growth
  • BNGO N/A
  • PFSA 66.67
  • 52 Week Low
  • BNGO $1.50
  • PFSA $0.27
  • 52 Week High
  • BNGO $28.12
  • PFSA $5.50
  • Technical
  • Relative Strength Index (RSI)
  • BNGO 39.61
  • PFSA N/A
  • Support Level
  • BNGO $1.63
  • PFSA N/A
  • Resistance Level
  • BNGO $1.85
  • PFSA N/A
  • Average True Range (ATR)
  • BNGO 0.11
  • PFSA 0.00
  • MACD
  • BNGO 0.05
  • PFSA 0.00
  • Stochastic Oscillator
  • BNGO 81.82
  • PFSA 0.00

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About PFSA Profusa Inc. Common Stock

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: